Yingshi Bio is an anti-cancer drug research and development manufacturer, focusing on breakthrough drug resistance of solid tumors and tumor microenvironment fibrosis drug research and development. Taking disease biology as the source of innovation, the company’s core layout is the research and development of innovative drugs for tumor fibrosis microenvironment, focusing on Breakthrough and lead the treatment of drug resistance and metastasis of solid tumors that lack treatment options, take translational medicine as the source of innovation, give full play to the advantages of strong clinical capabilities, and devote to creating an efficient platform from disease biological mechanism research, innovative drug discovery to clinical translation and proof-of-concept . Yingshi Bio has recently obtained the support of Shanghai Pudong Development Silicon Valley Bank’s ten million dollar debt financing.
This article is reproduced from: https://www.itjuzi.com/investevent/13372509
This site is for inclusion only, and the copyright belongs to the original author.